RS

Ravi Shankar Jasti

Director Director DIN 01787482
DIN 01787482 First appointment Jul 1999 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jul 1999
Shareholding value Locked Premium profile

About Ravi Shankar Jasti

Ravi Shankar Jasti has 27 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

DIN 01787482
Primary Designation Director
First Appointment 09 Jul 1999
Oldest Company Age 27 yrs

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Symet Drugs Private Limited U24231AP1999PTC032066
Director 09 Jul 1999 1999 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Symet Drugs Private Limited
Premium access

Shareholding and investment profile for Ravi Shankar Jasti

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravi Shankar Jasti

Ravi Shankar Jasti has 27 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

Ravi Shankar Jasti is associated with 0 companies as Director.

Ravi Shankar Jasti has expertise in General Business.

Ravi Shankar Jasti has 27 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available